Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
Abstract Background Diffuse alveolar bleeding is a potentially life-threatening condition that can be induced by several drugs. Whereas fatal cases have been reported in patients treated for other indications, no report have so far been published in a patient with multiple sclerosis treated with ale...
Main Authors: | Aija Zuleron Myro, Gisle Bjerke, Svetozar Zarnovicky, Trygve Holmøy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-018-0267-5 |
Similar Items
-
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
by: Trygve Holmøy, et al.
Published: (2019-08-01) -
Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies
by: Trygve Holmøy, et al.
Published: (2017-04-01) -
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT
by: Gaia Cipolla, et al.
Published: (2020-07-01) -
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis
by: Simona Rolla, et al.
Published: (2020-06-01) -
Meccanismo d’azione dei farmaci più recenti, Teriflunomide e Alemtuzumab e implicazioni terapeutiche
by: Francesco Patti
Published: (2015-11-01)